The Familial Mediterranean Fever Pharmaceuticals market size is expected to reach $2.21 billion in 2030 at a CAGR of 5.1%, driven by rise in gene therapy.
Read More
The Familial Amyloid Polyneuropathy market size is expected to reach $2.43 billion in 2030 at a CAGR of 8.0%, driven by rising gene therapy focus.
Read More
The Factor XII Inhibitors market size is expected to reach $2.34 billion in 2030 at a CAGR of 10.8%, driven by rising thrombotic disorders incidence.
Read More
Facet-Joint Injection Market Performance Outlook 2026–2030: Revenue to Hit $4.1 Billion at 6.6% CAGR
The Facet-Joint Injection market size is expected to reach $4.1 billion in 2030 at a CAGR of 6.6%, driven by rising chronic back pain prevalence.
Read MoreFacet-Joint Injection Market Performance Outlook 2026–2030: Revenue to Hit $4.1 Billion at 6.6% CAGR
The Facet-Joint Injection market size is expected to reach $4.1 billion in 2030 at a CAGR of 6.6%, driven by rising chronic back pain prevalence.
Read More
The Ipatasertib market size is expected to reach $1.6 billion in 2030 at a CAGR of 13.1%, driven by rising cancer prevalence.
Read More
Lymphocyte activating gene 3 (lag3) antibody market to reach $1.53 billion by 2030 at 13.9% CAGR, driven by rising cancer incidence.
Read More
Lyme disease vaccine market to reach $1.57 billion by 2030 at 7.0% CAGR, driven by increasing prevalence of lyme disease and rising healthcare expenditure.
Read More
Lung cancer drugs market to reach $88.06 billion by 2030 at 10.9% CAGR, driven by rising prevalence rate of lung cancer.
Read More
Lumbosacral radicular pain management market to reach $1.17 billion by 2030 at 5.4% CAGR, driven by rising prevalence of back pain disorders.
Read More